These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22105774)

  • 1. No association between bone mass and prolactin levels among patients with schizophrenia.
    Sugawara N; Yasui-Furukori N; Fujii A; Saito M; Sato Y; Nakagami T; Tsuchimine S; Kaneko S
    Hum Psychopharmacol; 2011 Dec; 26(8):596-601. PubMed ID: 22105774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopenia associated with increased prolactin and aging in psychiatric patients treated with prolactin-elevating antipsychotics.
    Liu-Seifert H; Kinon BJ; Ahl J; Lamberson S
    Ann N Y Acad Sci; 2004 Dec; 1032():297-8. PubMed ID: 15677434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of plasma magnesium and prolactin on quantitative ultrasound measurements of heel bone among schizophrenic patients.
    Renn JH; Yang NP; Chou P
    BMC Musculoskelet Disord; 2010 Feb; 11():35. PubMed ID: 20163720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic-induced hyperprolactinaemia in patients with schizophrenia: considerations in relation to bone mineral density.
    Stubbs B
    J Psychiatr Ment Health Nurs; 2009 Nov; 16(9):838-42. PubMed ID: 19824978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone remodeling, bone mass and weight gain in patients with stabilized schizophrenia in real-life conditions treated with long-acting injectable risperidone.
    Doknic M; Maric NP; Britvic D; Pekic S; Damjanovic A; Miljic D; Stojanovic M; Radojicic Z; Jasovic Gasic M; Popovic V
    Neuroendocrinology; 2011; 94(3):246-54. PubMed ID: 21986470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Antipsychotics on Bone Mineral Density and Sex Hormones in Male Patients with Schizophrenia.
    Bulut SD; Bulut S; Atalan DG; Tulaci RG; Türker T; Gürçay E; Aydemir Ç
    Psychiatr Danub; 2016 Sep; 28(3):255-262. PubMed ID: 27658834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal and stimulated levels of prolactin, TSH, and LH in serum of chronic schizophrenic patients long-term treated with neuroleptics: relations to psychopathology.
    Naber D; Ackenheil M; Laakmann G
    Adv Biochem Psychopharmacol; 1980; 24():419-23. PubMed ID: 6105792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia.
    Wang L; Yu L; Zhang AP; Fang C; Du J; Gu NF; Qin SY; Feng GY; Li XW; Xing QH; He L
    J Psychopharmacol; 2007 Nov; 21(8):837-42. PubMed ID: 17715206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of elevated serum prolactin on bone mineral density and bone metabolism in female patients with schizophrenia: a prospective study.
    Abraham G; Paing WW; Kaminski J; Joseph A; Kohegyi E; Josiassen RC
    Am J Psychiatry; 2003 Sep; 160(9):1618-20. PubMed ID: 12944336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density changes over a year in young females with schizophrenia: relationship to medication and endocrine variables.
    Meaney AM; O'Keane V
    Schizophr Res; 2007 Jul; 93(1-3):136-43. PubMed ID: 17467954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia.
    Nakajima M; Terao T; Iwata N; Nakamura J
    Pharmacopsychiatry; 2005 Jan; 38(1):17-9. PubMed ID: 15706461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between major Multidrug Resistance 1 (MDR1) gene polymorphisms and plasma concentration of prolactin during risperidone treatment in schizophrenic patients.
    Yasui-Furukori N; Tsuchimine S; Saito M; Nakagami T; Sato Y; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1230-4. PubMed ID: 17559997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV; Brown WA; Laughren TP
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of smoking status on the plasma concentration of prolactin already elevated by risperidone treatment in schizophrenia patients.
    Ohta C; Yasui-Furukori N; Furukori H; Tsuchimine S; Saito M; Nakagami T; Yoshizawa K; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):573-6. PubMed ID: 21216266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics.
    Naber D; Ackenheil M; Laakman G; Fischer H; von Werder K
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):325-30. PubMed ID: 6111094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation antipsychotics and bone turnover in schizophrenia.
    Okita K; Kanahara N; Nishimura M; Yoshida T; Yasui-Furukori N; Niitsu T; Yoshida T; Ishikawa M; Kimura H; Nomura F; Iyo M
    Schizophr Res; 2014 Aug; 157(1-3):137-41. PubMed ID: 24888527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis in patients with schizophrenia.
    Hummer M; Malik P; Gasser RW; Hofer A; Kemmler G; Moncayo Naveda RC; Rettenbacher MA; Fleischhacker WW
    Am J Psychiatry; 2005 Jan; 162(1):162-7. PubMed ID: 15625215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia.
    Meaney AM; Smith S; Howes OD; O'Brien M; Murray RM; O'Keane V
    Br J Psychiatry; 2004 Jun; 184():503-8. PubMed ID: 15172944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum prolactin and smoking status in chronic antipsychotic-treated male patients with schizophrenia.
    Zhang X; Bu R; Sha W; Wang X; Liu J; Chu X; Li J; Dong H; Liu Y; Qing J
    Psychiatry Res; 2013 Sep; 209(2):239-41. PubMed ID: 23684052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.